L Fong

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi request reprint Dendritic cells in cancer immunotherapy
    L Fong
    Departments of Pathology and Medicine, Stanford University School of Medicine, Palo Alto, California 94304, USA
    Annu Rev Immunol 18:245-73. 2000
  2. pmc Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
    L Fong
    Departments of Pathology, Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305, USA
    Proc Natl Acad Sci U S A 98:8809-14. 2001
  3. ncbi request reprint Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy
    L Fong
    Department of Pathology, Stanford University School of Medicine, Palo Alto, CA 94304, USA
    J Immunol 167:7150-6. 2001
  4. ncbi request reprint Differentiation of myeloid dendritic cells into CD8alpha-positive dendritic cells in vivo
    M Merad
    Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA
    Blood 96:1865-72. 2000
  5. ncbi request reprint Dendritic cells injected via different routes induce immunity in cancer patients
    L Fong
    Department of Pathology, Stanford University School of Medicine, Palo Alto, CA 94304, USA
    J Immunol 166:4254-9. 2001
  6. ncbi request reprint Gemifloxacin inhibits cytokine secretion by lipopolysaccharide stimulated human monocytes at the post-transcriptional level
    F Araujo
    Palo Alto Medical Foundation, Palo Alto, California 94301, USA
    Clin Microbiol Infect 10:213-9. 2004

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Dendritic cells in cancer immunotherapy
    L Fong
    Departments of Pathology and Medicine, Stanford University School of Medicine, Palo Alto, California 94304, USA
    Annu Rev Immunol 18:245-73. 2000
    ....
  2. pmc Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
    L Fong
    Departments of Pathology, Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305, USA
    Proc Natl Acad Sci U S A 98:8809-14. 2001
    ..Clinical response correlated with the expansion of CD8 tetramer(+) T cells, confirming the role of CD8 T cells in this treatment strategy...
  3. ncbi request reprint Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy
    L Fong
    Department of Pathology, Stanford University School of Medicine, Palo Alto, CA 94304, USA
    J Immunol 167:7150-6. 2001
    ..These results demonstrate that xenoantigen immunization can break tolerance to a self-Ag in humans, resulting in a clinically significant antitumor effect...
  4. ncbi request reprint Differentiation of myeloid dendritic cells into CD8alpha-positive dendritic cells in vivo
    M Merad
    Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA
    Blood 96:1865-72. 2000
    ..CD8alpha expression on these DC appears to reflect a state of activation, mobilization, or both, rather than lineage. (Blood. 2000;96:1865-1872)..
  5. ncbi request reprint Dendritic cells injected via different routes induce immunity in cancer patients
    L Fong
    Department of Pathology, Stanford University School of Medicine, Palo Alto, CA 94304, USA
    J Immunol 166:4254-9. 2001
    ..d. and two of six for i.l. routes. These results suggest that while activated DC can prime T cell immunity regardless of route, the quality of this response and induction of Ag-specific Abs may be affected by the route of administration...
  6. ncbi request reprint Gemifloxacin inhibits cytokine secretion by lipopolysaccharide stimulated human monocytes at the post-transcriptional level
    F Araujo
    Palo Alto Medical Foundation, Palo Alto, California 94301, USA
    Clin Microbiol Infect 10:213-9. 2004
    ....